US Stock MarketDetailed Quotes

HCW Biologics (HCWB)

Watchlist

1.280
-0.040-3.03%

Close Jun 12 15:59 ET

1.300
+0.020+1.56%

Post 20:01 ET

9.17MMarket Cap-0.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HCW Biologics (HCWB) Balance Sheet

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Assets

Current assets

Cash, cash equivalents and short term investments

10.95%1.23M

-58.23%1.95M

9.89%1.1M

110.02%2.44M

-72.88%1.11M

30.03%4.67M

-91.10%998.22K

-93.33%1.16M

-Cash and cash equivalents

10.95%1.23M

-58.23%1.95M

9.89%1.1M

110.02%2.44M

-72.88%1.11M

30.03%4.67M

-91.10%998.22K

-84.41%1.16M

Receivables

-14.46%74.84K

-94.47%32.18K

-95.30%30.67K

-96.70%21.61K

-92.42%87.49K

-62.09%582.2K

-8.20%651.84K

-7.39%654.97K

-Accounts receivable

-14.46%74.84K

-94.47%32.18K

-95.30%30.67K

-96.70%21.61K

-90.32%87.49K

-62.09%582.2K

-8.20%651.84K

-7.39%654.97K

Prepaid assets

16.18%297.76K

-32.31%222.16K

-40.85%210.66K

-27.01%295.54K

-67.29%256.29K

-68.52%328.18K

-79.56%356.16K

-70.15%404.92K

Other current assets

-72.97%119.84K

-31.68%77.56K

184.05%250.34K

-14.34%141.01K

136.73%443.31K

-50.84%113.53K

-49.61%88.13K

-49.67%164.61K

Total current assets

-9.15%1.72M

-59.91%2.28M

-24.15%1.59M

21.43%2.9M

-69.48%1.89M

-11.02%5.7M

-84.88%2.09M

-87.95%2.39M

Non current assets

Net PPE

-8.77%20.77M

-8.86%20.88M

-1.45%22.5M

-0.75%22.64M

0.76%22.76M

12.01%22.91M

54.48%22.83M

80.67%22.81M

-Gross PPE

----

-5.72%25.06M

----

13.21%26.59M

----

-Accumulated depreciation

----

-13.79%-4.18M

----

-21.26%-3.68M

----

Investments and advances

201.69%4.83M

-17.09%1.33M

109.31%3.35M

0.00%1.6M

Other non current assets

0.00%28.48K

-49.63%28.48K

-79.31%28.48K

-86.51%28.48K

Total non current assets

5.04%25.62M

-9.38%22.24M

-2.47%23.86M

6.46%26.01M

0.71%24.39M

10.98%24.54M

12.38%24.46M

24.13%24.43M

Total assets

4.02%27.34M

-18.91%24.52M

-4.18%25.45M

7.79%28.91M

-13.61%26.29M

6.04%30.24M

-25.44%26.56M

-32.07%26.82M

Liabilities

Current liabilities

Payables

-40.28%11.79M

-41.15%13.14M

-15.79%19.09M

14.80%19.44M

87.05%19.73M

262.11%22.33M

618.68%22.67M

700.22%16.93M

-accounts payable

-40.28%11.79M

-41.15%13.14M

-16.31%18.97M

14.68%19.35M

88.06%19.73M

262.11%22.33M

618.68%22.67M

697.53%16.88M

-Total tax payable

----

--120K

--87K

----

-Other payable

----

--57K

Current accrued expenses

-4.09%1.13M

13.05%1.11M

-7.26%980K

-83.80%974K

-57.75%1.17M

-61.95%981.94K

-53.30%1.06M

148.30%6.01M

Current debt and capital lease obligation

5.50%6.58M

7.83%6.81M

7.36%6.81M

5,078.39%6.42M

5,003.75%6.23M

--6.31M

--6.34M

--124K

-Current debt

5.50%6.58M

7.83%6.81M

7.36%6.81M

5,078.39%6.42M

5,003.75%6.23M

--6.31M

--6.34M

--124K

Current deferred liabilities

--470K

----

Other current liabilities

----

---15.4K

-93.62%9.42K

----

--147.68K

Current liabilities

-26.47%19.96M

-28.91%21.06M

-10.65%26.86M

15.62%26.85M

102.36%27.14M

238.71%29.63M

455.01%30.06M

411.67%23.22M

Non current liabilities

Long term debt and capital lease obligation

----

-96.29%367.15K

-6.88%7.71M

17.03%7.38M

2.05%6.46M

55.68%9.9M

-Long term debt

----

-96.29%367.15K

-6.88%7.71M

17.03%7.38M

2.05%6.46M

55.68%9.9M

Derivative product liabilities

--928.44K

----

Other non current liabilities

--692.53K

--1.75M

----

Total non current liabilities

-78.96%1.62M

-90.61%692.53K

-89.28%692.53K

-78.63%2.12M

-6.88%7.71M

17.03%7.38M

2.05%6.46M

55.68%9.9M

Total liabilities

-38.07%21.58M

-41.21%21.76M

-24.57%27.55M

-12.56%28.96M

60.68%34.85M

145.86%37.01M

210.88%36.53M

203.92%33.12M

Shareholders'equity

Share capital

-85.02%673

195.50%328

-93.07%262

-94.32%215

18.80%4.49K

-96.92%111

5.26%3.78K

-common stock

-85.02%673

195.50%328

-93.07%262

-94.32%215

18.80%4.49K

-96.92%111

5.26%3.78K

Retained earnings

-2.23%-105.04M

-7.92%-108.52M

-12.40%-109.24M

-12.22%-104.68M

-31.73%-102.75M

-42.57%-100.56M

-62.37%-97.18M

-69.87%-93.28M

Paid-in capital

17.64%110.81M

18.65%111.28M

22.84%107.13M

20.29%104.63M

8.59%94.19M

11.66%93.79M

4.17%87.21M

4.17%86.98M

Total stockholders'equity

167.30%5.76M

140.84%2.76M

78.86%-2.11M

99.18%-51.97K

-197.96%-8.56M

-150.29%-6.77M

-141.77%-9.97M

-122.04%-6.3M

Total equity

167.30%5.76M

140.84%2.76M

78.86%-2.11M

99.18%-51.97K

-197.96%-8.56M

-150.29%-6.77M

-141.77%-9.97M

-122.04%-6.3M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments	10.95%1.23M	-58.23%1.95M	-58.23%1.95M	9.89%1.1M	110.02%2.44M	-72.88%1.11M	30.03%4.67M	30.03%4.67M	-91.10%998.22K	-93.33%1.16M
-Cash and cash equivalents	10.95%1.23M	-58.23%1.95M	-58.23%1.95M	9.89%1.1M	110.02%2.44M	-72.88%1.11M	30.03%4.67M	30.03%4.67M	-91.10%998.22K	-84.41%1.16M
Receivables	-14.46%74.84K	-94.47%32.18K	-94.47%32.18K	-95.30%30.67K	-96.70%21.61K	-92.42%87.49K	-62.09%582.2K	-62.09%582.2K	-8.20%651.84K	-7.39%654.97K
-Accounts receivable	-14.46%74.84K	-94.47%32.18K	-94.47%32.18K	-95.30%30.67K	-96.70%21.61K	-90.32%87.49K	-62.09%582.2K	-62.09%582.2K	-8.20%651.84K	-7.39%654.97K
Prepaid assets	16.18%297.76K	-32.31%222.16K	-32.31%222.16K	-40.85%210.66K	-27.01%295.54K	-67.29%256.29K	-68.52%328.18K	-68.52%328.18K	-79.56%356.16K	-70.15%404.92K
Other current assets	-72.97%119.84K	-31.68%77.56K	-31.68%77.56K	184.05%250.34K	-14.34%141.01K	136.73%443.31K	-50.84%113.53K	-50.84%113.53K	-49.61%88.13K	-49.67%164.61K
Total current assets	-9.15%1.72M	-59.91%2.28M	-59.91%2.28M	-24.15%1.59M	21.43%2.9M	-69.48%1.89M	-11.02%5.7M	-11.02%5.7M	-84.88%2.09M	-87.95%2.39M
Non current assets
Net PPE	-8.77%20.77M	-8.86%20.88M	-8.86%20.88M	-1.45%22.5M	-0.75%22.64M	0.76%22.76M	12.01%22.91M	12.01%22.91M	54.48%22.83M	80.67%22.81M
-Gross PPE	----	-5.72%25.06M	-5.72%25.06M	----	----	----	13.21%26.59M	13.21%26.59M	----	----
-Accumulated depreciation	----	-13.79%-4.18M	-13.79%-4.18M	----	----	----	-21.26%-3.68M	-21.26%-3.68M	----	----
Investments and advances	201.69%4.83M	-17.09%1.33M	-17.09%1.33M	-17.09%1.33M	109.31%3.35M	0.00%1.6M	0.00%1.6M	0.00%1.6M	0.00%1.6M	0.00%1.6M
Other non current assets	0.00%28.48K	0.00%28.48K	0.00%28.48K	0.00%28.48K	0.00%28.48K	0.00%28.48K	-49.63%28.48K	-49.63%28.48K	-79.31%28.48K	-86.51%28.48K
Total non current assets	5.04%25.62M	-9.38%22.24M	-9.38%22.24M	-2.47%23.86M	6.46%26.01M	0.71%24.39M	10.98%24.54M	10.98%24.54M	12.38%24.46M	24.13%24.43M
Total assets	4.02%27.34M	-18.91%24.52M	-18.91%24.52M	-4.18%25.45M	7.79%28.91M	-13.61%26.29M	6.04%30.24M	6.04%30.24M	-25.44%26.56M	-32.07%26.82M
Liabilities
Current liabilities
Payables	-40.28%11.79M	-41.15%13.14M	-41.15%13.14M	-15.79%19.09M	14.80%19.44M	87.05%19.73M	262.11%22.33M	262.11%22.33M	618.68%22.67M	700.22%16.93M
-accounts payable	-40.28%11.79M	-41.15%13.14M	-41.15%13.14M	-16.31%18.97M	14.68%19.35M	88.06%19.73M	262.11%22.33M	262.11%22.33M	618.68%22.67M	697.53%16.88M
-Total tax payable	----	----	----	--120K	--87K	----	----	----	----	----
-Other payable	----	----	----	----	----	----	----	----	----	--57K
Current accrued expenses	-4.09%1.13M	13.05%1.11M	13.05%1.11M	-7.26%980K	-83.80%974K	-57.75%1.17M	-61.95%981.94K	-61.95%981.94K	-53.30%1.06M	148.30%6.01M
Current debt and capital lease obligation	5.50%6.58M	7.83%6.81M	7.83%6.81M	7.36%6.81M	5,078.39%6.42M	5,003.75%6.23M	--6.31M	--6.31M	--6.34M	--124K
-Current debt	5.50%6.58M	7.83%6.81M	7.83%6.81M	7.36%6.81M	5,078.39%6.42M	5,003.75%6.23M	--6.31M	--6.31M	--6.34M	--124K
Current deferred liabilities	--470K	----	----	----	----	----	----	----	----	----
Other current liabilities	----	----	----	---15.4K	-93.62%9.42K	----	----	----	----	--147.68K
Current liabilities	-26.47%19.96M	-28.91%21.06M	-28.91%21.06M	-10.65%26.86M	15.62%26.85M	102.36%27.14M	238.71%29.63M	238.71%29.63M	455.01%30.06M	411.67%23.22M
Non current liabilities
Long term debt and capital lease obligation	----	----	----	----	-96.29%367.15K	-6.88%7.71M	17.03%7.38M	17.03%7.38M	2.05%6.46M	55.68%9.9M
-Long term debt	----	----	----	----	-96.29%367.15K	-6.88%7.71M	17.03%7.38M	17.03%7.38M	2.05%6.46M	55.68%9.9M
Derivative product liabilities	--928.44K	----	----	----	----	----	----	----	----	----
Other non current liabilities	--692.53K	--692.53K	--692.53K	--692.53K	--1.75M	----	----	----	----	----
Total non current liabilities	-78.96%1.62M	-90.61%692.53K	-90.61%692.53K	-89.28%692.53K	-78.63%2.12M	-6.88%7.71M	17.03%7.38M	17.03%7.38M	2.05%6.46M	55.68%9.9M
Total liabilities	-38.07%21.58M	-41.21%21.76M	-41.21%21.76M	-24.57%27.55M	-12.56%28.96M	60.68%34.85M	145.86%37.01M	145.86%37.01M	210.88%36.53M	203.92%33.12M
Shareholders'equity
Share capital	-85.02%673	195.50%328	195.50%328	-93.07%262	-94.32%215	18.80%4.49K	-96.92%111	-96.92%111	5.26%3.78K	5.26%3.78K
-common stock	-85.02%673	195.50%328	195.50%328	-93.07%262	-94.32%215	18.80%4.49K	-96.92%111	-96.92%111	5.26%3.78K	5.26%3.78K
Retained earnings	-2.23%-105.04M	-7.92%-108.52M	-7.92%-108.52M	-12.40%-109.24M	-12.22%-104.68M	-31.73%-102.75M	-42.57%-100.56M	-42.57%-100.56M	-62.37%-97.18M	-69.87%-93.28M
Paid-in capital	17.64%110.81M	18.65%111.28M	18.65%111.28M	22.84%107.13M	20.29%104.63M	8.59%94.19M	11.66%93.79M	11.66%93.79M	4.17%87.21M	4.17%86.98M
Total stockholders'equity	167.30%5.76M	140.84%2.76M	140.84%2.76M	78.86%-2.11M	99.18%-51.97K	-197.96%-8.56M	-150.29%-6.77M	-150.29%-6.77M	-141.77%-9.97M	-122.04%-6.3M
Total equity	167.30%5.76M	140.84%2.76M	140.84%2.76M	78.86%-2.11M	99.18%-51.97K	-197.96%-8.56M	-150.29%-6.77M	-150.29%-6.77M	-141.77%-9.97M	-122.04%-6.3M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm